Teladoc Health, Inc. announced expanded capabilities to help health plans manage rising demand for anti-obesity medication such as glucagon-like peptide 1 (GLP-1) agonists. New features include helping plan sponsors and pharmacy benefit managers manage and optimize the growing complexity and costs associated with obesity management. The multidisciplinary care model is designed by clinicians experienced in obesity medicine and delivered with a tailored approach to weight management.